Get an alert when OXFORD BIOCITECH HOLDINGS LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-03-06 (in 10mo)

Last made up 2026-02-20

Watchouts

1 item

Cash

£4M

-44.3% vs 2023

Net assets

-£11M

-135.6% vs 2023

Employees

Average over period

Profit before tax

-£42M

-81.6% vs 2023

Watchouts

Facts from the Companies House register and the latest accounts — not a rating

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £3,635,847£2,972,219
Operating profit -£22,010,641-£39,611,038
Profit before tax -£23,280,431-£42,276,854
Net profit -£23,280,431-£42,276,854
Cash £6,657,981£3,709,456
Total assets less current liabilities £88,552,827£5,034,906
Net assets £30,982,148-£11,017,409
Equity £30,982,148-£11,017,409
Average employees
Wages

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -605.4%-1332.7%
Net margin -640.3%-1422.4%
Return on capital employed -24.9%-786.7%
Gearing (liabilities / total assets) 67.9%121.4%
Current ratio 2.42x0.22x
Interest cover -6.10x-10.18x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Consolidated group
Auditor
PricewaterhouseCoopers CI LLP
Audit opinion
Unqualified (clean)
Going concern
Material uncertainty disclosed

“In assessing whether the going concern basis of preparation is appropriate, the directors have identified the above two matters disclosed and have concluded to prepare the financial statements on a going concern basis with material uncertainties in relation to the future operations of the company after the sale of the asset and ability to settle its shareholder loans.”

Group structure

  1. OXFORD BIOCITECH HOLDINGS LIMITED · parent
    1. Pills TopCo SCI 100% · Luxembourg
    2. Pills AcquistioCo SCI 65% · Luxembourg
    3. Pills DevCo SCI 65% · Luxembourg

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

4 active · 7 resigned

Name Role Appointed Born Nationality
GEN II CORPORATE SERVICES (JERSEY) LIMITED Corporate Secretary 2022-10-27
DREXLER, Jay Director 2024-12-20 Aug 1984 Canadian
EVERALL, Robin James Ele William Director 2022-10-07 Dec 1980 English
RAWLINSON, Rebecca Mary Director 2026-04-21 May 1988 English
Show 7 resigned officers
Name Role Appointed Resigned
CRESTBRIDGE UK LIMITED Corporate Secretary 2022-02-21 2022-10-27
CHEN, Joy Director 2025-09-15 2026-04-21
HODGETTS, Ann Mary Director 2022-02-21 2023-05-22
LAMBERT, Alison Jane, Ms. Director 2022-02-21 2022-10-01
RAWLINSON, Rebecca Mary Director 2024-02-01 2025-04-24
SHAPIRO, Abigail Jane Director 2023-05-22 2024-12-20
SHEARER, Henry Charles Director 2022-02-21 2022-07-19

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Life Sciences (Uk) Holdings Ii Limited Corporate entity ownership-of-shares-75-to-100-percent-as-firm, voting-rights-75-to-100-percent-as-firm, right-to-appoint-and-remove-directors-as-firm 2022-02-21 Active

Filing timeline

Last 20 of 40 total filings

Date Type Category Description
2026-04-23 AP01 officers Appoint person director company with name date PDF
2026-04-23 TM01 officers Termination director company with name termination date PDF
2026-03-19 SH01 capital Capital allotment shares PDF
2026-03-02 CS01 confirmation-statement Confirmation statement with updates PDF
2026-02-06 SH01 capital Capital allotment shares PDF
2025-12-05 AA accounts Accounts with accounts type group
2025-09-16 AP01 officers Appoint person director company with name date PDF
2025-08-01 SH01 capital Capital allotment shares PDF
2025-05-12 SH01 capital Capital allotment shares PDF
2025-04-24 TM01 officers Termination director company with name termination date PDF
2025-03-04 CS01 confirmation-statement Confirmation statement with updates PDF
2025-01-03 RP04SH01 capital Second filing capital allotment shares PDF
2024-12-30 AP01 officers Appoint person director company with name date PDF
2024-12-27 TM01 officers Termination director company with name termination date PDF
2024-11-06 SH01 capital Capital allotment shares PDF
2024-10-21 AA accounts Accounts with accounts type total exemption full
2024-08-08 SH01 capital Capital allotment shares
2024-04-19 CH04 officers Change corporate secretary company with change date PDF
2024-02-29 CS01 confirmation-statement Confirmation statement with updates PDF
2024-02-28 SH01 capital Capital allotment shares PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
9

last 12 months

Capital events
7

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page